The Role of Post-treatment FDG-PET/CT Scanning after the First-line Chemotherapy in Predicting Prognosis in Patients with Hodgkin Disease and High-grade Non-Hodgkin Lymphoma: A Comparative Study with Clinical Prognostic Risk Scoring Data

---

ERDOĞAN E. B., Guner S., SÖNMEZOĞLU K.

BEZMIALEM SCIENCE, vol.10, no.3, pp.264-273, 2022 (ESCI)

• Publication Type: Article / Article
• Volume: 10 Issue: 3
• Publication Date: 2022
• Doi Number: 10.14235/bas.galenos.2021.5981
• Journal Name: BEZMIALEM SCIENCE
• Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
• Page Numbers: pp.264-273
• Keywords: Lymphoma, positron emission mography/computed tomography, F-18 fluorodeoxyglucose, clinical prognostic risk scores, POSITRON-EMISSION-TOMOGRAPHY, B-CELL LYMPHOMA, SUV-BASED ASSESSMENT, RESPONSE ASSESSMENT, F-18-FDG PET
• Open Archive Collection: AVESIS Open Access Collection
• Istanbul University Affiliated: No

Abstract

Objective: We aimed to evaluate the role of fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) performed after the first-line therapy in predicting prognosis of lymphomas and compare the results with the pretreatment prognostic risk scoring (PRS) indices.